Multicenter, Open Label, Phase II Trial to Evaluate the Efficacy and Safety of Treatment With Rituximab + CHOP Regimen in Patients With HIV Related Non-Hodgkin's Lymphomas. ANRS 085 Rituximab
Latest Information Update: 02 Nov 2021
At a glance
- Drugs Cyclophosphamide (Primary) ; Doxorubicin (Primary) ; Prednisone (Primary) ; Rituximab (Primary) ; Vincristine (Primary)
- Indications B-cell lymphoma; Burkitt's lymphoma; Diffuse large B cell lymphoma; Lymphoma; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- Acronyms ANRS 085 Rituximab
- 26 Aug 2020 New trial record